zintick

Jasper Therapeutics JSPR

Jasper Therapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$0.48-5.51%close on Nov. 3, 2026 · volume 255K · Yahoo Finance

Price, last 51 sessions

$0.50$0.60$0.70Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 3, 2026 · high $0.72 · low $0.48 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 19 →
  • 8-KNov. 4, 2026, 8:11 a.m. ETView on SEC.govOur explainer

    Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedJasper Therapeutics announces 1-for-30 reverse stock split effective November 6, 2026, cutting outstanding shares from about 33.3 million to about 1.1 million

  • SCHEDULE 13GOct. 28, 2026, 2:21 p.m. ETView on SEC.gov
  • 8-KOct. 15, 2026, 8 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KOct. 7, 2026, 8:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedJasper Therapeutics Launches $0.324-Per-Warrant Cash Tender Offer Costing About $4.0 Million

  • 8-KOct. 5, 2026, 8 a.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

  • 8-K/AOct. 2, 2026, 6:54 p.m. ETView on SEC.gov

    Financial statements and exhibits

  • 8-K/AOct. 1, 2026, 5:29 p.m. ETView on SEC.gov

    Financial statements and exhibits

  • 8-KSept. 28, 2026, 4:44 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers